Intellectual Property

Metabolon, Inc. has built an IP estate comprised of trademarks, copyrights, trade secrets and patents, including broad metabolomics method, data analysis and biomarker patents, and focused product patents that protect critical points along our value chain. Our patent portfolio stands out as the most substantial portfolio in the biochemical profiling (metabolomics) and small molecule diagnostics industries.

Metabolon, Inc. Patents and Patent Applications

Metabolon's patent portfolio is comprised of over 100 US and worldwide patents and patent applications, including pioneering patents in the field of metabolomics. Our data analysis and software patents cover critical aspects of our metabolomics platform, including collection and analysis of the massive amounts of data generated by metabolomics experiments and the identification of small molecules comprising complex mixtures. In addition, Metabolon has pending patents directed to small molecule biomarkers related to drug action, toxicity, carcinogens, aging and numerous diseases and disorders.

In 2007, Metabolon, Inc. acquired the metabolomics-related patent estate from Cogenics Icoria, a subsidiary of Clinical Data, Inc. The estate includes issued and pending patents related to data analysis and software as well as biomarkers of toxicity and carcinogenicity.

(Click to view the following portfolios)

Metabolomics Methods Portfolio

Technology Portfolio

Biomarkers and Diagnostics Portfolio

Issued Patents

  • US Patent 8’187’830. Method for Determining Insulin Sensitivity with Biomarkers. Issued 5/29/2012.
  • US Patent 8’175’816. System and Method for Analyzing Metabolomic Data. Issued 5/8/2012.
  • Japanese Patent 4’950’993. System, Method, and Computer Program Product Using a Database in a Computing System to Compile and Compare Metabolomic Data Obtained from a Plurality of Samples. Issued 3/16/2012.
  • US Patent 8’131’473. Data Analysis Methods for Locating Entities of Interest within Large, Multivariable Datasets. Issued 3/6/2012.
  • European Patent 2’089’539. Biomarkers Related to Metabolic Age and Methods Using the Same. Issued 12/7/2011.
  • US Patent 7’949’475. System and Method for Analyzing Metabolomic Data. Issued 5/24/2011.
  • US Patent 7’947’453. Methods for Drug Discovery, Disease Treatment, and Diagnosis Using Metabolomics. Issued 5/24/2011.
  • US Patent 7’910’301. Methods for Drug Discovery, Disease Treatment, and Diagnosis Using Metabolomics. Issued 3/22/2011.
  • US Patent 7’884’318. Systems, Methods, and Computer-Readable Medium for Determining Composition of Chemical Constituents in a Complex Mixture. Issued 2/8/2011.
  • US Patent 7’807’138. Biomarkers of Metabolic Responses to Hepatic Drugs. Issued 10/5/2010.
  • US Patent 7’781’160. Biomarkers Related to Metabolic Age and Methods Using the Same. Issued 8/24/2010.
  • US Patent 7’682’783. Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics. Issued 3/23/10.
  • US Patent 7’682’784. Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics. Issued 3/23/10.
  • US Patent 7’635’556. Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics. Issued 12/22/10.
  • US Patent 7’561’975. A System, Method and Computer Program Product for Analyzing Spectrometry Data to Identify and Quantify Individual Components in a Sample. Issued 7/14/09.
  • US Patent 7’553’616. Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics. Issued 6/30/09.
  • US Patent 7’550’258. Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics. Issued 6/23/09.
  • US Patent 7’550’260. Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics. Issued 6/23/09.
  • US Patent 7’433’787. A System, Method, and Computer Program Product Using a Database in a Computing System to Compile and Compare Metabolomic Data Obtained from a Plurality of Samples. Issued 10/7/08.
  • US Patent 7’329’489. Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics. Issued 2/12/2008. (Note: A Certificate of Correction was issued 5/12/08 by the USPTO.)
  • US Patent 7’005’255. Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics. Issued 2/28/2006.
  • US Patent 6’873’914. Methods and Systems for Analyzing Complex Biological Systems. Issued 3/29/2005.

Licensing

To exploit the strength of our IP portfolio, Metabolon, Inc. is offering licensing rights in areas outside of our strategic focus. For further information on licensing terms and conditions, please contact us.